Answers are grounded in this paper and cite their sources.
Continuous monitoring remains limited by the fact that most wearable biosensors are built around single-analyte recognition chemistries, even though many physiological states are defined by changes across multiple metabolites. Tear fluid is one of the most biochemically informative biofluids accessible non-invasively, but contact lens biosensors have largely relied on enzymatic or electrochemical techniques that are difficult to extend beyond one target marker at a time. Here, we report a label-free surface-enhanced Raman spectroscopy (SERS)-active contact lens in which gold nanostars are grown in situ on commercial hydrogel contact lenses. The resulting gold nanostar-loaded contact lens (AuNS-CL) introduces a plasmonic sensing layer directly onto the wearable substrate, with a substrate-averaged SERS enhancement factor of ∼105, while preserving the lens’ physiochemical properties. Quantitative biosensing was demonstrated using a digital thresholding method to account for variable hotspot distributions. Metabolites such as lactate and urea were quantified through their diagnostic bands in several solutions, including artificial tears and a mixture of tear analytes. The AuNS-CLs showed a strong linear response in the physiological range and recovery errors below 10%. To the best of our knowledge, this is the first demonstration of a wearable contact lens for label-free SERS quantification of tear metabolites.
No takes yet. Share an insight, caveat, or question.
Salih et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: